Healthcare Equipment and Supplies
Company Overview of LED Medical Diagnostics, Inc.
LED Medical Diagnostics Inc. develops and markets medical devices in the dental industry under the VELscope trade name in North America. Its products include Velscope Vx system, a device for the enhanced visualization of mucosal abnormalities, such as oral cancer and premalignant dysplasia; VELscope Vx imaging adapter for fluorescence and white-light clinical imaging; Vx VELcaps to prevent patient cross contamination; Vx VELsheaths, a single use plastic sheath to prevent patient cross contamination; and Vx Value Bundle, a portable handheld device used to conduct oral tissue examinations. The company also provides diagnostic imaging products and software to dental and oral health specialists....
235–5589 Byrne Road
Burnaby, BC V5J 3J1
Founded in 2003
Key Executives for LED Medical Diagnostics, Inc.
Chief Executive Officer and Director
Total Annual Compensation: $278.6K
Director and President of Led Dental Ltd
Total Annual Compensation: $244.9K
Compensation as of Fiscal Year 2015.
LED Medical Diagnostics, Inc. Key Developments
LED Medical Diagnostics Inc. Announces Preliminary Revenue Results for the Third Quarter and Nine Months Ended September 30, 2016
Oct 20 16
LED Medical Diagnostics Inc. announced preliminary revenue results for the third quarter and nine months ended September 30, 2016. For the quarter, the company reported gross revenue was $2.5 million, representing an approximate 39% increase over the prior year period of $1.8 million.
The company's revenue for the nine-month period ended September 30, 2016 was $8.3 million, a year-over-year increase of 11% as compared to the $7.5 million result from the same period of 2015.
LED Dental Inc. and LED Dental Ltd. Announce Launch of RAYSCAN Alpha Plus Imaging System from RAY Company
Sep 29 16
LED Medical Diagnostics Inc., through its wholly-owned US and Canadian operating subsidiaries, LED Dental Inc./LED Dental Ltd. ("LED Dental") announced the launch of the RAYSCAN Alpha Plus, a next-generation extraoral imaging system that is the latest innovation from RAY Company ("RAY"). Building upon the RAYSCAN Alpha platform, the RAYSCAN Alpha Plus continues RAY Company's dedication to delivering high-quality imaging technologies combined with features that break new ground in the industry. Clinicians can utilize the RAYSCAN Alpha Plus to capture high-resolution panoramic, cephalometric and cone beam computed tomography images. The panoramic modality allows for a variety of 2D panoramic examinations, including standard pano and segmented pano acquisitions, in addition to an extraoral bitewing feature. The CBCT modality of the RAYSCAN Alpha Plus boasts several features that allow practitioners to truly customize examinations to their patients unlike ever before. First, the Alpha Plus utilizes an innovative light-guided field-of-view that simplifies patient positioning to reduce errors and retakes. The desired field-of-view is super-imposed on the patient's face, allowing dental professionals to see the exact area being scanned in relation to the patient's actual anatomy, ensuring accurate image acquisition. Furthermore, the system adds to the innovative light-guided positioning feature by utilizing Free FOV technology, which makes the field-of-view completely customizable from While The RAYSCAN Alpha Plus continues to push new boundaries in terms of dose reduction, image quality and clarity remain the system's top priority. The CBCT modality delivers voxel resolutions as small as 70 m, making 3D images from the RAYSCAN Alpha Plus among the resolution in the industry. And, new proprietary algorithms allow for images to be reconstructed in as little as 4.9 seconds. Finally, the optional cephalometric module is available in either scanning or one-shot options, with the one-shot module acquiring images in less than one second to further reduce image distortion and lessen radiation dose. The RAYSCAN Alpha Plus is available now through LED Dental.
LED Medical Diagnostics, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2016 and Cash Flow Results for the Six Months Ended June 30, 2016
Aug 8 16
LED Medical Diagnostics, Inc. reported earnings results for the second quarter ended June 30, 2016 and cash flow results for the six months ended June 30, 2016. For the quarter, the company reported net revenue for the three months ended June 30, 2016 was USD 3,661,490, which is an increase of 12% from the three months ended June 30, 2015. This revenue increase was largely due to timing of when imaging orders were received and could be shipped and by increased demand for VELscope and VELscope consumable sales. The net loss before tax for the three months ended June 30, 2016 was USD 1,082,831 compared to the net loss before taxes for the three months ended June 30, 2015 of USD 1,205,742. The decrease of operating loss is mainly attributable to higher revenue levels and lower operating expense than in 2015. These favorable profit items were partially offset by higher stock option expense, interest expense and the absence of gains on the fair value of Canadian warrants.
For the six months, the company reported cash flow used in operations was USD 1,505,387 during the six months ended June 30, 2016 compared to cash flow used in operations of USD 3,086,535 during the six months ended June 30, 2015.
Similar Private Companies By Industry
Recent Private Companies Transactions
July 4, 2016